ClinicalTrials.gg
Drug

Tirbanibulin clinical trials

Also written KX2-391 and Klisyri®.

studies test it
18
open now
4
in phase 3
4
first study started
2007

How each study uses tirbanibulin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tirbanibulin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Dec 2020 · KLISYRI · NDA 213189 (FDA, Drugs@FDA)
European Union
16 Jul 2021 · Klisyri · EMEA/H/C/005183 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tirbanibulin
4
Tirbanibulin ointment 1%
4
KX01 ointment 1%
2

Brand

Klisyri®
2

Development codes

KX2-391
3
KX01
1

Studies by the year they started

18 studies that test it; most in 2023 (5)

Studies that test tirbanibulin, by start year
YearStudies
20071
20101
20121
20131
20151
20212
20222
20235
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
5
Phase 3
4
Phase 4
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 6

Almirall, S.A. (4) · PharmaEssentia (3) · Medical University of Graz (2) · Athenex, Inc. (2) · Austin Institute for Clinical Research (1) · Kinex Pharmaceuticals Inc. (1) · University Hospital, Lille (1) · Centre Hospitalier Universitaire de Nice (1)

Often tested with

Tested in the same studies.

Cryotherapy (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test tirbanibulin.

Studies

Open first, then newest update. How each study uses tirbanibulin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call tirbanibulin · ClinicalTrials.gg INT001552

  • MeSH (NLM) C000713668tirbanibulinOne source ClinicalTrials.gov
  • UNII (FDA) 4V9848RS5GTIRBANIBULINConfirmed FDA, Wikidata
  • RxNorm 2471078One source FDA
  • Wikidata Q27888424tirbanibulinConfirmed FDA, Wikidata
  • NCI Thesaurus C74077TirbanibulinOne source FDA
  • DrugBank DB06137One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.